Malin Corporation | MLC - Capitalisation Boursière

Prix De L'Action
7.95
Variation Quotidienne
0 0%
Mensuellement
3.25%
Annuel
-6.47%
Q2 Prévisions
7.71




Capitalisation Boursière Changement Date
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
ALKERMES USD 4.62B 333M 2025-12
Avita Medical AUD 105.47M 35.32M 2025-12
Dianthus Therapeutics USD 1.78B 215M 2025-12
Eurofins Scientific SE EUR 864.41M 10.5B 2026-04
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
IQVIA Holdings USD 29.18B 9.2B 2026-04
Lonza CHF 39.68B 980.61M 2025-06
Malin Corporation EUR 142.92M 19.65M 2026-02
Organon & Co USD 1.86B 916.43M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Revvity USD 10.97B 1.21B 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Viatris USD 14.34B 2.8B 2025-12
Xeris Pharmaceuticals USD 1.3B 12M 2025-12